Prophylactic Human Vaccine and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Prophylactic Human Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prophylactic Human Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prophylactic Human Vaccine Overall Market Size
2.1 Global Prophylactic Human Vaccine Market Size: 2023 VS 2030
2.2 Global Prophylactic Human Vaccine Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Prophylactic Human Vaccine Sales: 2019-2030
3 Company Landscape
3.1 Top Prophylactic Human Vaccine Players in Global Market
3.2 Top Global Prophylactic Human Vaccine Companies Ranked by Revenue
3.3 Global Prophylactic Human Vaccine Revenue by Companies
3.4 Global Prophylactic Human Vaccine Sales by Companies
3.5 Global Prophylactic Human Vaccine Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Prophylactic Human Vaccine Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Prophylactic Human Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Prophylactic Human Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Prophylactic Human Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Prophylactic Human Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Prophylactic Human Vaccine Market Size Markets, 2023 & 2030
4.1.2 Inactivated Vaccine
4.1.3 Attenuated Vaccine
4.1.4 Others
4.2 By Type - Global Prophylactic Human Vaccine Revenue & Forecasts
4.2.1 By Type - Global Prophylactic Human Vaccine Revenue, 2019-2024
4.2.2 By Type - Global Prophylactic Human Vaccine Revenue, 2025-2030
4.2.3 By Type - Global Prophylactic Human Vaccine Revenue Market Share, 2019-2030
4.3 By Type - Global Prophylactic Human Vaccine Sales & Forecasts
4.3.1 By Type - Global Prophylactic Human Vaccine Sales, 2019-2024
4.3.2 By Type - Global Prophylactic Human Vaccine Sales, 2025-2030
4.3.3 By Type - Global Prophylactic Human Vaccine Sales Market Share, 2019-2030
4.4 By Type - Global Prophylactic Human Vaccine Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Prophylactic Human Vaccine Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Scientific Research
5.1.4 Others
5.2 By Application - Global Prophylactic Human Vaccine Revenue & Forecasts
5.2.1 By Application - Global Prophylactic Human Vaccine Revenue, 2019-2024
5.2.2 By Application - Global Prophylactic Human Vaccine Revenue, 2025-2030
5.2.3 By Application - Global Prophylactic Human Vaccine Revenue Market Share, 2019-2030
5.3 By Application - Global Prophylactic Human Vaccine Sales & Forecasts
5.3.1 By Application - Global Prophylactic Human Vaccine Sales, 2019-2024
5.3.2 By Application - Global Prophylactic Human Vaccine Sales, 2025-2030
5.3.3 By Application - Global Prophylactic Human Vaccine Sales Market Share, 2019-2030
5.4 By Application - Global Prophylactic Human Vaccine Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Prophylactic Human Vaccine Market Size, 2023 & 2030
6.2 By Region - Global Prophylactic Human Vaccine Revenue & Forecasts
6.2.1 By Region - Global Prophylactic Human Vaccine Revenue, 2019-2024
6.2.2 By Region - Global Prophylactic Human Vaccine Revenue, 2025-2030
6.2.3 By Region - Global Prophylactic Human Vaccine Revenue Market Share, 2019-2030
6.3 By Region - Global Prophylactic Human Vaccine Sales & Forecasts
6.3.1 By Region - Global Prophylactic Human Vaccine Sales, 2019-2024
6.3.2 By Region - Global Prophylactic Human Vaccine Sales, 2025-2030
6.3.3 By Region - Global Prophylactic Human Vaccine Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Prophylactic Human Vaccine Revenue, 2019-2030
6.4.2 By Country - North America Prophylactic Human Vaccine Sales, 2019-2030
6.4.3 US Prophylactic Human Vaccine Market Size, 2019-2030
6.4.4 Canada Prophylactic Human Vaccine Market Size, 2019-2030
6.4.5 Mexico Prophylactic Human Vaccine Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Prophylactic Human Vaccine Revenue, 2019-2030
6.5.2 By Country - Europe Prophylactic Human Vaccine Sales, 2019-2030
6.5.3 Germany Prophylactic Human Vaccine Market Size, 2019-2030
6.5.4 France Prophylactic Human Vaccine Market Size, 2019-2030
6.5.5 U.K. Prophylactic Human Vaccine Market Size, 2019-2030
6.5.6 Italy Prophylactic Human Vaccine Market Size, 2019-2030
6.5.7 Russia Prophylactic Human Vaccine Market Size, 2019-2030
6.5.8 Nordic Countries Prophylactic Human Vaccine Market Size, 2019-2030
6.5.9 Benelux Prophylactic Human Vaccine Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Prophylactic Human Vaccine Revenue, 2019-2030
6.6.2 By Region - Asia Prophylactic Human Vaccine Sales, 2019-2030
6.6.3 China Prophylactic Human Vaccine Market Size, 2019-2030
6.6.4 Japan Prophylactic Human Vaccine Market Size, 2019-2030
6.6.5 South Korea Prophylactic Human Vaccine Market Size, 2019-2030
6.6.6 Southeast Asia Prophylactic Human Vaccine Market Size, 2019-2030
6.6.7 India Prophylactic Human Vaccine Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Prophylactic Human Vaccine Revenue, 2019-2030
6.7.2 By Country - South America Prophylactic Human Vaccine Sales, 2019-2030
6.7.3 Brazil Prophylactic Human Vaccine Market Size, 2019-2030
6.7.4 Argentina Prophylactic Human Vaccine Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Prophylactic Human Vaccine Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Prophylactic Human Vaccine Sales, 2019-2030
6.8.3 Turkey Prophylactic Human Vaccine Market Size, 2019-2030
6.8.4 Israel Prophylactic Human Vaccine Market Size, 2019-2030
6.8.5 Saudi Arabia Prophylactic Human Vaccine Market Size, 2019-2030
6.8.6 UAE Prophylactic Human Vaccine Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 GSK
7.1.1 GSK Company Summary
7.1.2 GSK Business Overview
7.1.3 GSK Prophylactic Human Vaccine Major Product Offerings
7.1.4 GSK Prophylactic Human Vaccine Sales and Revenue in Global (2019-2024)
7.1.5 GSK Key News & Latest Developments
7.2 Biovac
7.2.1 Biovac Company Summary
7.2.2 Biovac Business Overview
7.2.3 Biovac Prophylactic Human Vaccine Major Product Offerings
7.2.4 Biovac Prophylactic Human Vaccine Sales and Revenue in Global (2019-2024)
7.2.5 Biovac Key News & Latest Developments
7.3 McKesson Medical
7.3.1 McKesson Medical Company Summary
7.3.2 McKesson Medical Business Overview
7.3.3 McKesson Medical Prophylactic Human Vaccine Major Product Offerings
7.3.4 McKesson Medical Prophylactic Human Vaccine Sales and Revenue in Global (2019-2024)
7.3.5 McKesson Medical Key News & Latest Developments
7.4 Merck
7.4.1 Merck Company Summary
7.4.2 Merck Business Overview
7.4.3 Merck Prophylactic Human Vaccine Major Product Offerings
7.4.4 Merck Prophylactic Human Vaccine Sales and Revenue in Global (2019-2024)
7.4.5 Merck Key News & Latest Developments
7.5 Merial
7.5.1 Merial Company Summary
7.5.2 Merial Business Overview
7.5.3 Merial Prophylactic Human Vaccine Major Product Offerings
7.5.4 Merial Prophylactic Human Vaccine Sales and Revenue in Global (2019-2024)
7.5.5 Merial Key News & Latest Developments
7.6 Zoetis
7.6.1 Zoetis Company Summary
7.6.2 Zoetis Business Overview
7.6.3 Zoetis Prophylactic Human Vaccine Major Product Offerings
7.6.4 Zoetis Prophylactic Human Vaccine Sales and Revenue in Global (2019-2024)
7.6.5 Zoetis Key News & Latest Developments
7.7 Sanofi
7.7.1 Sanofi Company Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Prophylactic Human Vaccine Major Product Offerings
7.7.4 Sanofi Prophylactic Human Vaccine Sales and Revenue in Global (2019-2024)
7.7.5 Sanofi Key News & Latest Developments
8 Global Prophylactic Human Vaccine Production Capacity, Analysis
8.1 Global Prophylactic Human Vaccine Production Capacity, 2019-2030
8.2 Prophylactic Human Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Prophylactic Human Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Prophylactic Human Vaccine Supply Chain Analysis
10.1 Prophylactic Human Vaccine Industry Value Chain
10.2 Prophylactic Human Vaccine Upstream Market
10.3 Prophylactic Human Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Prophylactic Human Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Prophylactic Human Vaccine in Global Market
Table 2. Top Prophylactic Human Vaccine Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Prophylactic Human Vaccine Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Prophylactic Human Vaccine Revenue Share by Companies, 2019-2024
Table 5. Global Prophylactic Human Vaccine Sales by Companies, (K Units), 2019-2024
Table 6. Global Prophylactic Human Vaccine Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Prophylactic Human Vaccine Price (2019-2024) & (USD/Unit)
Table 8. Global Manufacturers Prophylactic Human Vaccine Product Type
Table 9. List of Global Tier 1 Prophylactic Human Vaccine Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prophylactic Human Vaccine Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Prophylactic Human Vaccine Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Prophylactic Human Vaccine Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Prophylactic Human Vaccine Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Prophylactic Human Vaccine Sales (K Units), 2019-2024
Table 15. By Type - Global Prophylactic Human Vaccine Sales (K Units), 2025-2030
Table 16. By Application ? Global Prophylactic Human Vaccine Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Prophylactic Human Vaccine Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Prophylactic Human Vaccine Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Prophylactic Human Vaccine Sales (K Units), 2019-2024
Table 20. By Application - Global Prophylactic Human Vaccine Sales (K Units), 2025-2030
Table 21. By Region ? Global Prophylactic Human Vaccine Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Prophylactic Human Vaccine Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Prophylactic Human Vaccine Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Prophylactic Human Vaccine Sales (K Units), 2019-2024
Table 25. By Region - Global Prophylactic Human Vaccine Sales (K Units), 2025-2030
Table 26. By Country - North America Prophylactic Human Vaccine Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Prophylactic Human Vaccine Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Prophylactic Human Vaccine Sales, (K Units), 2019-2024
Table 29. By Country - North America Prophylactic Human Vaccine Sales, (K Units), 2025-2030
Table 30. By Country - Europe Prophylactic Human Vaccine Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Prophylactic Human Vaccine Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Prophylactic Human Vaccine Sales, (K Units), 2019-2024
Table 33. By Country - Europe Prophylactic Human Vaccine Sales, (K Units), 2025-2030
Table 34. By Region - Asia Prophylactic Human Vaccine Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Prophylactic Human Vaccine Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Prophylactic Human Vaccine Sales, (K Units), 2019-2024
Table 37. By Region - Asia Prophylactic Human Vaccine Sales, (K Units), 2025-2030
Table 38. By Country - South America Prophylactic Human Vaccine Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Prophylactic Human Vaccine Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Prophylactic Human Vaccine Sales, (K Units), 2019-2024
Table 41. By Country - South America Prophylactic Human Vaccine Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Prophylactic Human Vaccine Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Prophylactic Human Vaccine Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Prophylactic Human Vaccine Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Prophylactic Human Vaccine Sales, (K Units), 2025-2030
Table 46. GSK Company Summary
Table 47. GSK Prophylactic Human Vaccine Product Offerings
Table 48. GSK Prophylactic Human Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 49. GSK Key News & Latest Developments
Table 50. Biovac Company Summary
Table 51. Biovac Prophylactic Human Vaccine Product Offerings
Table 52. Biovac Prophylactic Human Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 53. Biovac Key News & Latest Developments
Table 54. McKesson Medical Company Summary
Table 55. McKesson Medical Prophylactic Human Vaccine Product Offerings
Table 56. McKesson Medical Prophylactic Human Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 57. McKesson Medical Key News & Latest Developments
Table 58. Merck Company Summary
Table 59. Merck Prophylactic Human Vaccine Product Offerings
Table 60. Merck Prophylactic Human Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 61. Merck Key News & Latest Developments
Table 62. Merial Company Summary
Table 63. Merial Prophylactic Human Vaccine Product Offerings
Table 64. Merial Prophylactic Human Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 65. Merial Key News & Latest Developments
Table 66. Zoetis Company Summary
Table 67. Zoetis Prophylactic Human Vaccine Product Offerings
Table 68. Zoetis Prophylactic Human Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 69. Zoetis Key News & Latest Developments
Table 70. Sanofi Company Summary
Table 71. Sanofi Prophylactic Human Vaccine Product Offerings
Table 72. Sanofi Prophylactic Human Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 73. Sanofi Key News & Latest Developments
Table 74. Prophylactic Human Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2022-2024 (K Units)
Table 75. Global Prophylactic Human Vaccine Capacity Market Share of Key Manufacturers, 2022-2024
Table 76. Global Prophylactic Human Vaccine Production by Region, 2019-2024 (K Units)
Table 77. Global Prophylactic Human Vaccine Production by Region, 2025-2030 (K Units)
Table 78. Prophylactic Human Vaccine Market Opportunities & Trends in Global Market
Table 79. Prophylactic Human Vaccine Market Drivers in Global Market
Table 80. Prophylactic Human Vaccine Market Restraints in Global Market
Table 81. Prophylactic Human Vaccine Raw Materials
Table 82. Prophylactic Human Vaccine Raw Materials Suppliers in Global Market
Table 83. Typical Prophylactic Human Vaccine Downstream
Table 84. Prophylactic Human Vaccine Downstream Clients in Global Market
Table 85. Prophylactic Human Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Prophylactic Human Vaccine Segment by Type in 2023
Figure 2. Prophylactic Human Vaccine Segment by Application in 2023
Figure 3. Global Prophylactic Human Vaccine Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Prophylactic Human Vaccine Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Prophylactic Human Vaccine Revenue, 2019-2030 (US$, Mn)
Figure 7. Prophylactic Human Vaccine Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Prophylactic Human Vaccine Revenue in 2023
Figure 9. By Type - Global Prophylactic Human Vaccine Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Prophylactic Human Vaccine Revenue Market Share, 2019-2030
Figure 11. By Type - Global Prophylactic Human Vaccine Sales Market Share, 2019-2030
Figure 12. By Type - Global Prophylactic Human Vaccine Price (USD/Unit), 2019-2030
Figure 13. By Application - Global Prophylactic Human Vaccine Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Prophylactic Human Vaccine Revenue Market Share, 2019-2030
Figure 15. By Application - Global Prophylactic Human Vaccine Sales Market Share, 2019-2030
Figure 16. By Application - Global Prophylactic Human Vaccine Price (USD/Unit), 2019-2030
Figure 17. By Region - Global Prophylactic Human Vaccine Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Prophylactic Human Vaccine Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Prophylactic Human Vaccine Revenue Market Share, 2019-2030
Figure 20. By Region - Global Prophylactic Human Vaccine Sales Market Share, 2019-2030
Figure 21. By Country - North America Prophylactic Human Vaccine Revenue Market Share, 2019-2030
Figure 22. By Country - North America Prophylactic Human Vaccine Sales Market Share, 2019-2030
Figure 23. US Prophylactic Human Vaccine Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Prophylactic Human Vaccine Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Prophylactic Human Vaccine Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Prophylactic Human Vaccine Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Prophylactic Human Vaccine Sales Market Share, 2019-2030
Figure 28. Germany Prophylactic Human Vaccine Revenue, (US$, Mn), 2019-2030
Figure 29. France Prophylactic Human Vaccine Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Prophylactic Human Vaccine Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Prophylactic Human Vaccine Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Prophylactic Human Vaccine Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Prophylactic Human Vaccine Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Prophylactic Human Vaccine Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Prophylactic Human Vaccine Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Prophylactic Human Vaccine Sales Market Share, 2019-2030
Figure 37. China Prophylactic Human Vaccine Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Prophylactic Human Vaccine Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Prophylactic Human Vaccine Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Prophylactic Human Vaccine Revenue, (US$, Mn), 2019-2030
Figure 41. India Prophylactic Human Vaccine Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Prophylactic Human Vaccine Revenue Market Share, 2019-2030
Figure 43. By Country - South America Prophylactic Human Vaccine Sales Market Share, 2019-2030
Figure 44. Brazil Prophylactic Human Vaccine Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Prophylactic Human Vaccine Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Prophylactic Human Vaccine Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Prophylactic Human Vaccine Sales Market Share, 2019-2030
Figure 48. Turkey Prophylactic Human Vaccine Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Prophylactic Human Vaccine Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Prophylactic Human Vaccine Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Prophylactic Human Vaccine Revenue, (US$, Mn), 2019-2030
Figure 52. Global Prophylactic Human Vaccine Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Prophylactic Human Vaccine by Region, 2023 VS 2030
Figure 54. Prophylactic Human Vaccine Industry Value Chain
Figure 55. Marketing Channels
Industry Market Size
